134 related articles for article (PubMed ID: 31701298)
1. Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors.
Folkert IW; Sinnamon AJ; Concors SJ; Bennett BJ; Fraker DL; Mahmoud NN; Metz DC; Stashek KM; Roses RE
Ann Surg Oncol; 2020 Mar; 27(3):855-863. PubMed ID: 31701298
[TBL] [Abstract][Full Text] [Related]
2. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
[TBL] [Abstract][Full Text] [Related]
3. A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum.
Smith JD; Reidy DL; Goodman KA; Shia J; Nash GM
Ann Surg Oncol; 2014 Sep; 21(9):2956-62. PubMed ID: 24763982
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Metastases in Rectal Neuroendocrine Tumors: Results of a National Cohort Study.
Concors SJ; Sinnamon AJ; Folkert IW; Mahmoud NN; Fraker DL; Paulson EC; Roses RE
Dis Colon Rectum; 2018 Dec; 61(12):1372-1379. PubMed ID: 30312223
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data.
Wang Y; Zhang Y; Lin H; Xu M; Zhou X; Zhuang J; Yang Y; Chen B; Liu X; Guan G
J Surg Oncol; 2021 Dec; 124(7):1098-1105. PubMed ID: 34291822
[TBL] [Abstract][Full Text] [Related]
7. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
Choi JS; Kim MJ; Shin R; Park JW; Heo SC; Jeong SY; Park KJ; Ryoo SB
Ann Surg Oncol; 2024 Apr; 31(4):2414-2424. PubMed ID: 38194045
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
[TBL] [Abstract][Full Text] [Related]
10. ASO Author Reflections: Revisiting Risk of Dissemination from Small Rectal Neuroendocrine Tumors.
Folkert IW; Roses RE
Ann Surg Oncol; 2020 Mar; 27(3):864-865. PubMed ID: 31749081
[No Abstract] [Full Text] [Related]
11. Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE).
Fine C; Roquin G; Terrebonne E; Lecomte T; Coriat R; Do Cao C; de Mestier L; Coffin E; Cadiot G; Nicolli P; Lepiliez V; Hautefeuille V; Ramos J; Girot P; Dominguez S; Céphise FV; Forestier J; Hervieu V; Pioche M; Walter T
United European Gastroenterol J; 2019 Oct; 7(8):1102-1112. PubMed ID: 31662867
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
[TBL] [Abstract][Full Text] [Related]
13. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
[TBL] [Abstract][Full Text] [Related]
14. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
15. When is neoadjuvant chemotherapy indicated in rectal neuroendocrine tumors? An analysis of the National Cancer Database.
Gefen R; Emile SH; Horesh N; Garoufalia Z; Freund MR; Wexner SD
Tech Coloproctol; 2024 May; 28(1):56. PubMed ID: 38772962
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
18. Modified staging system for extremity soft tissue sarcomas.
Ramanathan RC; A'Hern R; Fisher C; Thomas JM
Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Recurrence in Pancreatic Neuroendocrine Tumor and Size as a Surrogate in Determining the Treatment Strategy: A Korean Nationwide Study.
Kwon W; Jang JY; Song KB; Hwang DW; Kim SC; Heo JS; Choi DW; Hwang HK; Kang CM; Yoon YS; Han HS; Park JS; Hong TH; Cho CK; Ahn KS; Lee H; Lee SE; Jeong CY; Roh YH; Kim HJ;
Neuroendocrinology; 2021; 111(8):794-804. PubMed ID: 33002889
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.
Chi Y; Du F; Zhao H; Wang JW; Cai JQ
World J Gastroenterol; 2014 Nov; 20(43):16252-7. PubMed ID: 25473180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
